[go: up one dir, main page]

AR128004A1 - Péptidos antigénicos y métodos para utilizarlos en el diagnóstico de la enfermedad de chagas - Google Patents

Péptidos antigénicos y métodos para utilizarlos en el diagnóstico de la enfermedad de chagas

Info

Publication number
AR128004A1
AR128004A1 ARP220103479A ARP220103479A AR128004A1 AR 128004 A1 AR128004 A1 AR 128004A1 AR P220103479 A ARP220103479 A AR P220103479A AR P220103479 A ARP220103479 A AR P220103479A AR 128004 A1 AR128004 A1 AR 128004A1
Authority
AR
Argentina
Prior art keywords
diagnosis
methods
antigenic peptides
chagas disease
cruzi
Prior art date
Application number
ARP220103479A
Other languages
English (en)
Inventor
Eric Dumonteil
Claudia Herrera
Original Assignee
16
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 16 filed Critical 16
Publication of AR128004A1 publication Critical patent/AR128004A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente divulgación proporciona novedosos péptidos antigénicos y mezclas peptídicas, y métodos para utilizarlos en la detección de anticuerpos contra T. cruzi en muestras de tejido y en el diagnóstico de la enfermedad de Chagas en un sujeto.
ARP220103479A 2021-12-17 2022-12-16 Péptidos antigénicos y métodos para utilizarlos en el diagnóstico de la enfermedad de chagas AR128004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163290972P 2021-12-17 2021-12-17

Publications (1)

Publication Number Publication Date
AR128004A1 true AR128004A1 (es) 2024-03-20

Family

ID=86773571

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103479A AR128004A1 (es) 2021-12-17 2022-12-16 Péptidos antigénicos y métodos para utilizarlos en el diagnóstico de la enfermedad de chagas

Country Status (3)

Country Link
US (1) US20250138007A1 (es)
AR (1) AR128004A1 (es)
WO (1) WO2023114960A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117069798B (zh) * 2023-08-21 2024-05-24 南京财经大学 一种抗炎活性的藜麦小肽及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
WO2009099580A2 (en) * 2008-02-05 2009-08-13 Monsanto Technology, Llc Isolated novel nucleic acid and protein molecules from soy and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
US11130994B2 (en) * 2019-12-13 2021-09-28 Autonomous Medical Devices Inc. Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method

Also Published As

Publication number Publication date
WO2023114960A1 (en) 2023-06-22
US20250138007A1 (en) 2025-05-01

Similar Documents

Publication Publication Date Title
CL2022002335A1 (es) Anticuerpos contra sars-cov-2 y métodos para usarlos
CL2019000067A1 (es) Anticuerpos nuevos que se unen específicamente a los epítopos del virus del zika y usos de los mismos.
AR117658A2 (es) Anticuerpos anti-fap y métodos de uso
AR082149A1 (es) Anticuerpos contra el virus sincicial respiratorio (rsv) humano y metodos para su uso
DOP2019000059A (es) Anticuerpos de unión a cd3
PE20231376A1 (es) Anticuerpos contra el sars-cov-2 y metodos e seleccion y uso de los mismos
BR112019011186A2 (pt) conjugado de anticorpo radiomarcado, composto, e, métodos de imageamento e para tratamento de um tumor.
CL2022000030A1 (es) Moléculas de unión a claudina-6 y usos de las mismas
PE20131403A1 (es) Anticuerpos anti-ox40 y metodos de uso de los mismos
GT201300233A (es) Receptores de celulas t similares a anticuerpos especificos para un peptido wt1 presentado por hla-a2
BR112016016737A2 (pt) Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma
PE20081686A1 (es) Proteinas de fusion que comprenden un antigeno prame (dage)
PE20141561A1 (es) Anticuerpos anti-lrp5 y metodos de uso
AR098126A1 (es) Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos
PE20131411A1 (es) Anticuerpos contra la tweak humana y usos de los mismos
MX2015000686A (es) Metodo para detectar cancer.
BR112016014010A2 (pt) métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreador
AR128004A1 (es) Péptidos antigénicos y métodos para utilizarlos en el diagnóstico de la enfermedad de chagas
CR20200061A (es) Tratamiento con obinutuzumab nuevo subgrupo de pacientes con nuevo linfoma de células b grandes difusas (dlbcl)
MX2017013177A (es) Anticuerpo anti-vegfr2 humano para terapia del cancer anti-angiogenica y dirigida.
CO2023013550A2 (es) Polipéptido de unión a gucy2c y usos del mismo
AR069047A1 (es) Peptidos y lipopeptidos sinteticos antigenicos derivados de mycobacterium avium subsp. paratuberculosis
MX377864B (es) Composición de antígeno para detectar enfermedad de chagas.
MX2021012848A (es) Mirikizumab para su uso en un metodo de tratamiento de la enfermedad de crohn.
RU2013125191A (ru) Способ ранней диагностики синдрома жировой эмболии при переломах длинных трубчатых костей и костей таза

Legal Events

Date Code Title Description
FA Abandonment or withdrawal